Expectant management of severe pre-eclampsia in the mid-trimester

Eur J Obstet Gynecol Reprod Biol. 2001 Jun;96(2):168-72. doi: 10.1016/s0301-2115(00)00449-8.

Abstract

Objective: To determine maternal and perinatal outcomes with expectant management of severe pre-eclampsia in the mid-trimester, using a defined entry point.

Design: Prospective case series. Thirty-nine women admitted from 24 to 27 week's gestation with severe pre-eclampsia, whose pregnancies were otherwise stable, were managed expectantly with careful clinical and biochemical monitoring of maternal and foetal status, together with careful blood pressure control, in a high-care obstetric ward. The aim was to safely prolong the pregnancies and thereby improve perinatal outcome.

Results: Gestation was prolonged by a median of 12 (range 3--47) days, with greater periods gained at earlier gestations. The overall perinatal loss was 26% and the neonatal loss 17%. The rates of significant maternal complications were low.

Conclusion: Expectant management of selected women with severe pre-eclampsia from 24 to 27 weeks' gestation in a tertiary care unit is acceptably safe and improves perinatal outcome.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Birth Weight
  • Female
  • Fetal Growth Retardation / complications
  • Fetal Monitoring
  • Gestational Age*
  • HELLP Syndrome / complications
  • Humans
  • Hypertension / therapy
  • Infant Mortality
  • Infant, Newborn
  • Intensive Care, Neonatal
  • Length of Stay
  • Pre-Eclampsia / therapy*
  • Pregnancy
  • Pregnancy Trimester, Second
  • Prospective Studies